Search

James Noble Kochenderfer

from Bethesda, MD
Age ~55
Get Report
Also known as:
James N Kochenderfer, James Nobel Kochenderfer, James M Kochenderfer, Ja Kochenderfer, Jim Kochenderfer
Phone and address:
8500 Rosewood Dr, Bethesda, MD 20814
(301) 571-1541
Related to:
Mark D Kochenderfer, 51James P Silvers, 79Janice M Gollub, 75Ruth A Kochenderfer, 55Sharon R SilversJanice Mary Silvers, 75Sharon R Silvers, 48Ruth A Silvers, 67
Connected to:
Alec Kochendorfer, 27Eileen V Kochendorfer, 104Frank D Kochenderfer, 75John H Kochenderfer, 134Linda M Kochendoerfer, 75Spencer T Kochendoerfer, 36Teena M Kochendarfer, 53Thomas A Kochendorfer, 60Aleksandr V Kochenkov, 61Bradley M Kochenour, 44

James Kochenderfer Phones & Addresses

  • 8500 Rosewood Dr, Bethesda, MD 20814 (301) 571-1541
  • 423 Pecore St, Houston, TX 77009
  • 7490 Brompton St, Houston, TX 77025 (713) 218-7508
  • 7530 Brompton St, Houston, TX 77025
  • 10301 Grosvenor Pl, Rockville, MD 20852 (301) 571-1541
  • Nashville, TN

Work

Company: National cancer institute (nci) Position: Physician-scientist

Education

School / High School: West Virginia University 1995

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Hematology, 2001

Industries

Research

Specialities

Hematology

Professional Records

Medicine Doctors

James Kochenderfer Photo 1

Dr. James N Kochenderfer, Bethesda MD - MD (Doctor of Medicine)

View page
Specialties:
Hematology
Address:
8500 Rosewood Dr, Bethesda, MD 20814
Certifications:
Hematology, 2001
Internal Medicine, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
West Virginia University
Graduated: 1995
James Kochenderfer Photo 2

James Noble Kochenderfer

View page
Specialties:
Internal Medicine
Hematology
Medical Oncology
Education:
West Virginia University (1995)

Resumes

Resumes

James Kochenderfer Photo 3

Physician-Scientist

View page
Location:
Washington, DC
Industry:
Research
Work:
National Cancer Institute (Nci)
Physician-Scientist
Education:
National Cancer Institute

Business Records

Name / Title
Company / Classification
Phones & Addresses
James Noble Kochenderfer
James Kochenderfer MD
Internist
8500 Rosewood Dr, Bethesda, MD 20814

Publications

Us Patents

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20230050416, Feb 16, 2023
Filed:
Oct 6, 2022
Appl. No.:
17/938529
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The U.S.A., as represented by the Secretary, Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/18
C07K 16/28
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20230030998, Feb 2, 2023
Filed:
Oct 6, 2022
Appl. No.:
17/938535
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The U.S.A., as represented by the Secretary, Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/18
C07K 16/28
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20230002776, Jan 5, 2023
Filed:
May 16, 2022
Appl. No.:
17/745067
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20210123063, Apr 29, 2021
Filed:
Dec 10, 2020
Appl. No.:
17/117311
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20210095294, Apr 1, 2021
Filed:
Dec 10, 2020
Appl. No.:
17/117335
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20210095295, Apr 1, 2021
Filed:
Dec 10, 2020
Appl. No.:
17/117368
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20200102567, Apr 2, 2020
Filed:
Nov 14, 2019
Appl. No.:
16/683417
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Chimeric Antigen Receptors Targeting B-Cell Maturation Antigen

View page
US Patent:
20200087667, Mar 19, 2020
Filed:
Nov 14, 2019
Appl. No.:
16/683477
Inventors:
- Bethesda MD, US
James N. Kochenderfer - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
International Classification:
C12N 15/62
C07K 14/705
C07K 14/725
C07K 16/28
C07K 16/18
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.
Control profile
James Noble Kochenderfer from Bethesda, MD, age ~55 Get Report